NEW YORK, Dec. 3 (GenomeWeb News) - Nanogen announced today it has received a new patent covering the assembly of nucleic acid-based nanotechnology structures.
The patent, No. 6,652,808, was granted Nov. 25 and is entitled "Methods for the Electronic Assembly and Fabrication of Devices." It details methods to use an electric field to assist in self-assembly of programmable nucleic acids and structures that are building blocks for "molecular electronic and photonic mechanisms," as well as nanostructures, and means to communicate between nanostructures. It also describes how these nanostructures can be assembled.
"The technology described by Nanogen's new patent may provide a technological foundation for the effective use of nanocomponents in many diverse applications," Howard Birndorf, Nanogen chairman and CEO, said in a statement.
The company intends to license out its nanotechnology patents or develop partnerships for their use, Birndorf said.
This is the ninth patent that Nanogen has received in 2003, the company said, and it has received 56 US patents in total.